Factor Bioscience Inc. 13D and 13G filings for BROOKLYN IMMUNO THERAPEUTICS L:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-27 5:26 pm Purchase |
2021-08-27 | 13G | Eterna Therapeutics Inc. ERNA |
Factor Bioscience Inc. | 233,549 9.000% |
233,549 (New Position) |
Filing |